- Home
- Industry Reports
- Biotechnology
- Healthcare
- Europe Newborn Screening Market – Size, Outlook, Trends and Forecast (2024 – 2032)
Newborn screening is a health program for screening newborns right after birth to identify problems that affect child’s health in future. Newborns are more liable to infections, which occurs on their first day of life. Newborn screening contains series of test which helps to detect the diseases and diagnosis are preventing inborn disability and deaths. These programs will change from country to another depending on the surroundings and legal requirements for a screening test.
Europe Newborn Screening Market Segments Size & Growth:
Europe Newborn Screening Market is accounted for $ XX billion in 2017 and expected to grow at a CAGR of XX% to reach $XX billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth by an increase in neonatal diseases, creating awareness on neonatal hereditary, funding by the government organisations, and advancement in technology. However, delays in hospitalisation, lack of advanced instruments hinder the growth of the Europenewborn screening market.
Europe Newborn Screening Market Segments Share:
Europe Newborn Screening Market is categorised into by test type which consists of hearing screening test, critical congenital heart disease test, and dry blood spot test. Critical congenital heart disease test has the most significant share because of increase in critical congenital heart defects. By product, Europenewborn screening market is segmented as pulse oximetry, newborn disorder screening instruments, hearing screening devices & accessories, reagents & assay kits. Among all newborn disorder screening instruments are expected to have high growth rate during the forecast period 2018-2024, due to increase in adoption of the screening test. The technology is segregated into DNA based array, electrophoresis, hearing screen technology, pulse oximetry technology. DNA based array is expected to have the most extensive share in the market owing to rise in genetic disorders.
By Geography, Germany is dominating the protein expression market, and the growth in Europe is mainly attributed because of the increasing adoption of the screening test and to reduce healthcare cost. Furthermore, UK is witnessing the fastest growth during the forecast period, due to rising patients, healthcare expenditure, and government funding.
Europe Newborn Screening Market Segments Trends:
- Trivitron Healthcare begins ultisys digital radiography system for a broad range of clinical application including general radiography.
- In September 2017, Natus Medical acquired Integra LifeSciences to have some medical assets and to enter the market.
- Thermo Fisher Scientific Inc. has acquired Patheon to enter into the (CDMO)Contract Development and Manufacturing Organization market in May 2017.
EuropeNewborn Screening Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Covidien PLC
- Waters Corporation
- Zen Tech S.A.
- Thermo Fisher Scientific, Inc.
- Masimo Corporation Bio-Rad Laboratories
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s five force analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1Increasing awareness
4.1.2 Augmenting array of newborn diseases
4.1.3Technological developments in healthcare.
4.2 Restraints
4.2.1 Lack of advanced instruments
4.2.2 Lack skilled professionals.
4.3 Opportunities
4.3.1 Investment by private investors with diagnostic centres
4.4 Challenges
4.4.1.Reduce side effects
4.4.2. Cost effective.
Chapter 5 Europe Newborn Screening Market- By Test Type
5.1 Hearing Screening Test
5.2Critical Congenital Heart Disease (CCHD) Test
5.3Dry blood Spot Test
Chapter 6 Europe Newborn Screening Market- By Product
6.1Pulse Oximetry
6.2 Newborn disorder Screening Instruments
6.3 Hearing screening devices and Accessories
6.4Reagents and assay kits
Chapter 7 EuropeNewborn Screening Market- By Technology
7.1 DNA based assay
7.2 Electrophoresis
7.3 Hearing Screen Technology
7.4 Pulse Oximetry Technology
7.5 Others
Chapter 8 EuropeNewborn Screening Market- By Geography
8.1 Introduction
8.2Europe
8.2.1. U.K.
8.2.2. Germany
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
Chapter 9 EuropeNewborn Screening Market- Company Profiles
9.1. Neogen Labs Pvt. Ltd.
9.2.AB Sciex LLC
9.3.Natus Medical
9.4.GE Healthcare
9.5.Bio-Rad Laboratories
9.6.Cardinal Health, Inc.
9.7.Agilent Technologies
9.8.Covidien PLC
9.9.Waters Corporation
9.10.Zen Tech S.A.
9.11.Thermo Fisher Scientific, Inc.
9.12.Masimo Corporation
9.13.PerkinElmer Inc.
9.14.Trivitron Healthcare
9.15.Medtronic Plc
Chapter 10 EuropeNewborn Screening Market- Competitive Landscape
10.1.Market Share Analysis
10.2.Strategies Adopted by top companies
10.3.Mergers, Acquisitions, Collaborations & Agreements
Chapter 11 Market Insights
11.1. Industry Experts Insights
11.2.Analysts Opinions
11.3.Investment Opportunities
Chapter 12 Appendix
12.1 List of Tables
12.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Regional Report
$2,160.00 – $7,200.00
- EUR: €2,027.60 - €6,758.66
- INR: ₹180,299.68 - ₹600,998.93
- AED: د.إ7,927.20 - د.إ26,424.00
- GBP: £1,736.03 - £5,786.76
Description
Regional Reports
Additional information
Report Type | Extensive Report, Miniature report, Snapshot Report |
---|---|
Licence | Single User License, Team License, Corporate License |
Newborn screening is a health program for screening newborns right after birth to identify problems that affect child’s health in future. Newborns are more liable to infections, which occurs on their first day of life. Newborn screening contains series of test which helps to detect the diseases and diagnosis are preventing inborn disability and deaths. These programs will change from country to another depending on the surroundings and legal requirements for a screening test.
Europe Newborn Screening Market Segments Size & Growth:
Europe Newborn Screening Market is accounted for $ XX billion in 2017 and expected to grow at a CAGR of XX% to reach $XX billion by 2024 during the forecast period 2018-2024. Major factors that are driving the market growth by an increase in neonatal diseases, creating awareness on neonatal hereditary, funding by the government organisations, and advancement in technology. However, delays in hospitalisation, lack of advanced instruments hinder the growth of the Europenewborn screening market.
Europe Newborn Screening Market Segments Share:
Europe Newborn Screening Market is categorised into by test type which consists of hearing screening test, critical congenital heart disease test, and dry blood spot test. Critical congenital heart disease test has the most significant share because of increase in critical congenital heart defects. By product, Europenewborn screening market is segmented as pulse oximetry, newborn disorder screening instruments, hearing screening devices & accessories, reagents & assay kits. Among all newborn disorder screening instruments are expected to have high growth rate during the forecast period 2018-2024, due to increase in adoption of the screening test. The technology is segregated into DNA based array, electrophoresis, hearing screen technology, pulse oximetry technology. DNA based array is expected to have the most extensive share in the market owing to rise in genetic disorders.
By Geography, Germany is dominating the protein expression market, and the growth in Europe is mainly attributed because of the increasing adoption of the screening test and to reduce healthcare cost. Furthermore, UK is witnessing the fastest growth during the forecast period, due to rising patients, healthcare expenditure, and government funding.
Europe Newborn Screening Market Segments Trends:
- Trivitron Healthcare begins ultisys digital radiography system for a broad range of clinical application including general radiography.
- In September 2017, Natus Medical acquired Integra LifeSciences to have some medical assets and to enter the market.
- Thermo Fisher Scientific Inc. has acquired Patheon to enter into the (CDMO)Contract Development and Manufacturing Organization market in May 2017.
EuropeNewborn Screening Research Report:
An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
To have complete market analysis, industry value chain analysis, Porter’s Five Force Analysis, PESTLE, SWOT analysis, and Y-o-Y analysis were carried to understand the market more comprehensively.
Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
Identifying DROC in the current market and their impact in altering the market dynamics.
Competitive landscape analysis to identify the mergers and acquisitions which will have a comparative financial study with significant competitors.
Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Covidien PLC
- Waters Corporation
- Zen Tech S.A.
- Thermo Fisher Scientific, Inc.
- Masimo Corporation Bio-Rad Laboratories
Chapter 1 Introduction
1.1 Executive Summary
1.2 Market Definition
1.3 Scope of the Study
Chapter 2 Research Methodology
2.1 Secondary Research
2.2 Primary Research
2.3 Analytic Tools and Model
2.4 Economic Indicator
2.4.1 Base Year, Base Currency, Forecasting Period
2.5 Expert Validation
2.6 Study Timeline
Chapter 3 Market Analysis
3.1 Industry Value Chain Analysis
3.2Porter’s five force analysis
3.2.1 Bargaining Power of Buyers
3.2.2 Bargaining Power of Suppliers
3.2.3 Threats of Substitutes
3.2.4 Threats of New Entrants
3.2.5 Industry Rivalry
3.3 Pestle Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4 SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.5 Y-O-Y Analyses
Chapter 4 Market Dynamics
4.1. Drivers
4.1.1Increasing awareness
4.1.2 Augmenting array of newborn diseases
4.1.3Technological developments in healthcare.
4.2 Restraints
4.2.1 Lack of advanced instruments
4.2.2 Lack skilled professionals.
4.3 Opportunities
4.3.1 Investment by private investors with diagnostic centres
4.4 Challenges
4.4.1.Reduce side effects
4.4.2. Cost effective.
Chapter 5 Europe Newborn Screening Market- By Test Type
5.1 Hearing Screening Test
5.2Critical Congenital Heart Disease (CCHD) Test
5.3Dry blood Spot Test
Chapter 6 Europe Newborn Screening Market- By Product
6.1Pulse Oximetry
6.2 Newborn disorder Screening Instruments
6.3 Hearing screening devices and Accessories
6.4Reagents and assay kits
Chapter 7 EuropeNewborn Screening Market- By Technology
7.1 DNA based assay
7.2 Electrophoresis
7.3 Hearing Screen Technology
7.4 Pulse Oximetry Technology
7.5 Others
Chapter 8 EuropeNewborn Screening Market- By Geography
8.1 Introduction
8.2Europe
8.2.1. U.K.
8.2.2. Germany
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Europe
Chapter 9 EuropeNewborn Screening Market- Company Profiles
9.1. Neogen Labs Pvt. Ltd.
9.2.AB Sciex LLC
9.3.Natus Medical
9.4.GE Healthcare
9.5.Bio-Rad Laboratories
9.6.Cardinal Health, Inc.
9.7.Agilent Technologies
9.8.Covidien PLC
9.9.Waters Corporation
9.10.Zen Tech S.A.
9.11.Thermo Fisher Scientific, Inc.
9.12.Masimo Corporation
9.13.PerkinElmer Inc.
9.14.Trivitron Healthcare
9.15.Medtronic Plc
Chapter 10 EuropeNewborn Screening Market- Competitive Landscape
10.1.Market Share Analysis
10.2.Strategies Adopted by top companies
10.3.Mergers, Acquisitions, Collaborations & Agreements
Chapter 11 Market Insights
11.1. Industry Experts Insights
11.2.Analysts Opinions
11.3.Investment Opportunities
Chapter 12 Appendix
12.1 List of Tables
12.2 List of Figures
- Competitive Analysis in marketing and strategic management is an assessment of the strengths and weaknesses of current and potential competitors.
- Monitoring the external and internal factors which affect the market dynamics with the aid of PESTLE analysis.
- The Regional and Global Variety is taken care of in the report.
- Year on Year basis generation of revenue is studied.
- Porter's Five Forces analyze the intensity of competition in an industry and its profitability level.
- The overview and the sustainability of the market are analyzed through SWOT.
- DROC (Drivers, Restraints, Opportunities and Challenges) is recognized in the current market scenario and see how its effect on market dynamics.
- The segment-level analysis in terms of type and technology.
- The value chain analysis, value that's created and captured by a company is the profit margin.
- Value Created and Captured – Cost of Creating that Value = Margin
- An executive summary consists of the whole report and the outcome is been given in the report to have brief knowledge about the report.
- Basis on the depth of the study we approach using analytical tools
- Expertise investment opportunities are given after analyzing the market to give the organization and the individual to have perfect knowledge about the market.
Our Clientele
Exclusive Benefits
Credibility and Transparency
We actively recruit consumers, business professionals, and hard-to-reach individuals as members of our research panels, and we build trusted, ongoing relationships with them. Thus we provide the complete list of primary and secondary data sources in the report to maintain the transparency and to assure the credibility.
Exhaustive Coverage
Detailed and extensive coverage in the geography.Survey consultation for brand tracking, concept testing, consumer behaviour, and more, we have you covered with market research services that scale to meet your needs.
Competitive Edge
Our reports cover most recent updates in the market till the date of the purchase. We identify, gather and timely deliver analysis on impact of unprecedented decisions of CXOs in COVID-19 catastrophe on many businesses, their clients and their clients' clients without additional cost.
Golden Opportunities
A comprehensive strategic sieve analysis of the market by our analysts and consultants, aided by AI tools helps us find the non-obvious, golden and emerging opportunities for you to evaluate.
Top-notch Reports Guaranteed
70% of our research is exclusive; no other research firm has the depth and breadth of our research.
Post Purchase Support
Post-purchase support is provided for all our reports, for three months from the date of purchase, where related queries will be answered within 24 business hours over telephone or email.